Preoperative PIV may serve as a simple and readily available adjunctive biomarker to assist in malignancy risk stratification of AUS/FLUS thyroid nodules. Its use may contribute to more informed surgical decision-making and help reduce unnecessary surgical interventions. Prospective studies are warranted to validate these findings and to determine clinically relevant cutoff values.
Yildirim et al. (Wed,) studied this question.